• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Prolonged viral shedding in pandemic influenza A H1N1: clinical significance and viral load analysis in hospitalized patients

tetano

Editor, Senior Moderator
Clin Microbiol Infect. 2010 Oct 14. doi: 10.1111/j.1469-0691.2010.03399.x. [Epub ahead of print]
Prolonged viral shedding in pandemic influenza A H1N1: clinical significance and viral load analysis in hospitalized patients.

Giannella M, Alonso M, Viedma DG, Roa PL, Catal?n P, Padilla B, Mu?oz P, Bouza E.

Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Mara??n, Madrid CIBER de Enfermedades Respiratorias (CIBERES), Spain.
Abstract

The clinical significance of prolonged viral shedding (PVS) and viral load (VL) dynamics has not been sufficiently assessed in hospitalized patients with pandemic 2009 influenza A. We performed a prospective study of adults with confirmed (H1N1)v infection admitted to our hospital from 20-09-09 to 31-12-09. Consecutive nasopharyngeal swabs were collected every two days during the first week after diagnosis, then every week or until viral detection was negative. Relative VL was measured on the basis of hemagglutinin and RNaseP gene analysis. PVS was defined as positive detection of (H1N1)v by real-time reverse transcriptase polymerase chain reaction at day 7 after diagnosis. We studied 64 patients: 16 (25%) presented PVS. The factors associated with PVS were admission to the ICU (69% vs. 33%, P=0.02), purulent expectoration (75% vs. 44%, P=0.04), higher dosage of oseltamivir (62.5% vs. 27%, P=0.016), corticosteroid treatment (50% vs. 21%, p=0.05), mechanical ventilation (MV) (50% vs. 12.5%, P=0.004), and longer stay (34 vs. 7 median days, P=0.003). Multivariate analysis revealed the factors independently associated with PVS to be immunosuppression (OR 5.15; 95% CI, 1.2-22.2; P=0.03) and the need for MV (OR 11.7; 95% CI, 2.5-54.4; P=0.002). VL at diagnosis correlated negatively with age and septic shock. VL dynamics of patients with acute respiratory distress syndrome and/or mortality was very different from that of other patients. PVS was detected in 25% of hospitalized patients with pandemic 2009 influenza A and was strongly associated with immunosuppression and need for MV. Diagnostic VL and viral clearance varied with the clinical course.
Copyright ? 2010 European Society of Clinical Microbiology and Infectious.

PMID: 20946412 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/20946412
 
Back
Top